Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2B90

Crystal structure of the interleukin-4 variant T13DR85A

2B90 の概要
エントリーDOI10.2210/pdb2b90/pdb
関連するPDBエントリー2B8U 2B8X 2B8Y 2B8Z 2B91 2D48
分子名称Interleukin-4, SULFATE ION (3 entities in total)
機能のキーワードfour helix bundle, cytokine
由来する生物種Homo sapiens (human)
細胞内の位置Secreted: P05112
タンパク質・核酸の鎖数1
化学式量合計15205.30
構造登録者
Kraich, M.,Klein, M.,Patino, E.,Harrer, H.,Sebald, W.,Mueller, T.D. (登録日: 2005-10-10, 公開日: 2006-05-30, 最終更新日: 2024-10-23)
主引用文献Kraich, M.,Klein, M.,Patino, E.,Harrer, H.,Nickel, J.,Sebald, W.,Mueller, T.D.
A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor
Bmc Biol., 4:13-13, 2006
Cited by
PubMed Abstract: Interleukin 4 (IL-4) is a key regulator of the immune system and an important factor in the development of allergic hypersensitivity. Together with interleukin 13 (IL-13), IL-4 plays an important role in exacerbating allergic and asthmatic symptoms. For signal transduction, both cytokines can utilise the same receptor, consisting of the IL-4Ralpha and the IL-13Ralpha1 chain, offering an explanation for their overlapping biological functions. Since both cytokine ligands share only moderate similarity on the amino acid sequence level, molecular recognition of the ligands by both receptor subunits is of great interest. IL-4 and IL-13 are interesting targets for allergy and asthma therapies. Knowledge of the binding mechanism will be important for the generation of either IL-4 or IL-13 specific drugs.
PubMed: 16640778
DOI: 10.1186/1741-7007-4-13
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.1 Å)
構造検証レポート
Validation report summary of 2b90
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon